Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Anemia, Sickle Cell D000755 34 associated lipids
Aspergillosis D001228 5 associated lipids
Blastomycosis D001759 5 associated lipids
Body Weight D001835 333 associated lipids
Burns D002056 34 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dermatomycoses D003881 17 associated lipids
Gonorrhea D006069 7 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Van Leeuwen MR et al. The polyene antimycotics nystatin and filipin disrupt the plasma membrane, whereas natamycin inhibits endocytosis in germinating conidia of Penicillium discolor. 2009 J. Appl. Microbiol. pmid:19228256
Carter GC et al. HIV entry in macrophages is dependent on intact lipid rafts. 2009 Virology pmid:19185899
Llabot JM et al. Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance. 2009 J Pharm Sci pmid:18803261
Xu L et al. Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts. 2009 FEBS Lett. pmid:19223002
Ganesan K et al. Prophylactic oral nystatin for preterm babies under 33 weeks' gestation decreases fungal colonisation and invasive fungaemia. 2009 Arch. Dis. Child. Fetal Neonatal Ed. pmid:19036756
Wong AM et al. Apical versus basolateral P2Y(6) receptor-mediated Cl(-) secretion in immortalized bronchial epithelia. 2009 Am. J. Respir. Cell Mol. Biol. pmid:19011163
Volkmer E et al. Successful nystatin powder treatment of posttraumatic invasive Aspergillus fumigatus wound infection refractory to systemic antifungal therapy. 2009 J Trauma pmid:18815576
Koide N et al. Nystatin-induced nitric oxide production in mouse macrophage-like cell line RAW264.7. 2009 Microbiol. Immunol. pmid:19457171
Migalovich HS et al. Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media. 2009 Cancer Res. pmid:19509228
de la Borbolla JM et al. Late reaction to oral nystatin: the importance of patch testing. 2009 J Investig Allergol Clin Immunol pmid:19639730
Lamberti Y et al. Cholesterol-dependent attachment of human respiratory cells by Bordetella pertussis. 2009 FEMS Immunol. Med. Microbiol. pmid:19385994
Signoretto C et al. Support for the role of Candida spp. in extensive caries lesions of children. 2009 New Microbiol. pmid:19382675
Woo KY et al. Peristomal skin complications and management. 2009 Adv Skin Wound Care pmid:20026934
Marconi M et al. Potassium current in mature bovine spermatozoa. 2008 Nov-Dec Syst Biol Reprod Med pmid:19052961
Yin X et al. Differential signaling pathways in angiotensin II- and epidermal growth factor-stimulated hepatic C9 cells. 2008 Mol. Pharmacol. pmid:18687808
Liu G et al. Nystatin interferes with the effects of N-methyl-N'-nitro-N-nitrosoguanidine on sphingolipid metabolism in human FL cells. 2008 Lipids pmid:18629562
Oji C and Chukwuneke F Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. 2008 Oral Maxillofac Surg pmid:18618163
Su CW et al. Clinical inquiries. What is the best treatment for oral thrush in healthy infants? 2008 J Fam Pract pmid:18625176
McFarland MJ et al. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells. 2008 Mol. Pharmacol. pmid:18436710
Placzek EA et al. Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. 2008 J. Neurochem. pmid:18778304